Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% | -.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Walter Messier
FOU | Founder | 69 | 31/10/90 |
Steve Warnecke
CEO | Chief Executive Officer | 68 | 31/08/10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Warnecke
CEO | Chief Executive Officer | 68 | 31/08/10 |
Mark Boggess
BRD | Director/Board Member | 64 | 31/12/09 |
Founder | 74 | 31/10/90 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 189,337 | 0 | 0 | 67.35 % |
Stock B | 1 | 6,655,232 | 4,482,324 ( 67.35 %) | 0 | |
Stock C | 0 | 577,063 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.99M | |
+43.34% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- FNAM Stock
- Company Evolutionary Genomics, Inc.